Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Aeglea BioTherapeutics, Inc. (AGLE)
Pharmaceutical Preparations
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases. The company competes in the segments of the pharmaceutical, biotechnology and other related markets that address rare genetic diseases.
221 CRESCENT STREET, BUILDING 23, SUITE 105
WALTHAM, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/07/2016
Market Cap
48,627,649
Shares Outstanding
4,050,000
Weighted SO
4,048,927
Total Employees
N/A
Upcoming Earnings
03/07/2024
Beta
2.5720
Last Div
0.0000
Range
2.66-24.0
Chg
0.7500
Avg Vol
59537
Mkt Cap
48627649
Exch
NASDAQ
Country
US
Phone
512 942 2935
DCF Diff
3.6207
DCF
8.3893
Div Yield
0.0000
P/S
46.1363
EV Multiple
-0.4014
P/FV
-0.2101
Div Yield %
0.0000
P/E
-0.1751
PEG
-0.2739
Payout
0.0000
Current Ratio
4.5897
Quick Ratio
4.5410
Cash Ratio
2.0189
DSO
56.4469
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
1.0000
Op Margin
-204.5076
Pretax Margin
-279.3359
Net Margin
-279.3472
Eff Tax Rate
0.0000
ROA
-1.4206
ROE
3.1933
ROCE
-1.3273
NI/EBT
1.0000
EBT/EBIT
1.3659
EBIT/Rev
-204.5076
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
21555.1000
CF/Debt
0.0000
Equity Multi
-0.8446
Rec Turnover
6.4663
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0051
OCF/Share
-20.2650
FCF/Share
-20.2650
Cash/Share
47.4168
OCF/Sales
-82.5560
FCF/OCF
1.0000
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
-0.2101
P/B
-0.2101
P/S
46.1363
P/E
-0.1751
P/FCF
-0.5588
P/OCF
-0.5926
P/CF
-0.5926
PEG
-0.2739
P/S
46.1363
EV Multiple
-0.4014
P/FV
-0.2101
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Revenue | 1.48M | ▼ 0.00 | 0.00 | 0.00 | ▲ 3.64M | ▼ 168.00K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.48M | ▼ 0.00 | 0.00 | 0.00 | ▲ 3.64M | ▼ 168.00K | ▼ 0.00 |
Gross Profit Ratio | 1.00 | ▼ 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 | ▼ 0.00 |
Research And Development Expenses | 5.79M | ▲ 11.80M | ▲ 17.57M | ▼ 15.76M | ▲ 16.78M | ▼ 14.25M | ▲ 24.66M |
General And Administrative Expenses | 2.32M | ▲ 3.51M | ▲ 4.34M | ▲ 7.02M | ▲ 7.30M | ▼ 5.08M | ▲ 8.58M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 2.32M | ▲ 3.51M | ▲ 4.34M | ▲ 7.02M | ▲ 7.30M | ▼ 5.08M | ▲ 8.58M |
Other Expenses | -7.00K | ▼ -20.00K | ▲ -18.00K | ▲ 18.00K | ▼ -15.00K | ▼ -32.00K | ▲ 2.34M |
Operating Expenses | 8.11M | ▲ 15.31M | ▲ 21.91M | ▲ 22.78M | ▲ 24.09M | ▼ 19.33M | ▲ 33.24M |
Cost And Expenses | 8.11M | ▲ 15.31M | ▲ 21.91M | ▲ 22.78M | ▲ 24.09M | ▼ 19.33M | ▲ 33.24M |
Interest Income | 150.00K | ▲ 427.00K | ▲ 432.00K | ▼ 44.00K | ▼ 34.00K | ▲ 410.00K | ▲ 1.25M |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 410.00K | ▼ 0.00 |
Depreciation And Amortization | 66.00K | ▲ 72.00K | ▲ 106.00K | ▲ 369.00K | ▲ 411.00K | ▼ 385.00K | ▼ 0.00 |
Ebitda | -6.56M | ▼ -15.23M | ▼ -21.91M | ▼ -22.41M | ▲ -20.03M | ▲ -18.78M | ▲ -18.34M |
Ebitda Ratio | -4.43 | ▲ 0.00 | 0.00 | 0.00 | ▼ -5.50 | ▼ -100.00 | ▲ 0.00 |
Operating Income | -6.63M | ▼ -15.31M | ▼ -21.91M | ▼ -22.78M | ▲ -20.44M | ▲ -19.16M | ▲ -18.34M |
Operating Income Ratio | -4.47 | ▲ 0.00 | 0.00 | 0.00 | ▼ -5.61 | ▼ -114.06 | ▲ 0.00 |
Total Other Income Expenses Net | -7.00K | ▼ -20.00K | ▲ -18.00K | ▲ 18.00K | ▼ -15.00K | ▲ 378.00K | ▼ -21.77M |
Income Before Tax | -6.48M | ▼ -14.90M | ▼ -21.50M | ▼ -22.71M | ▲ -20.42M | ▲ -18.78M | ▼ -40.10M |
Income Before Tax Ratio | -4.37 | ▲ 0.00 | 0.00 | 0.00 | ▼ -5.60 | ▼ -100.00 | ▲ 0.00 |
Income Tax Expense | -150.00K | ▼ -427.00K | ▼ -538.00K | ▲ -44.00K | ▲ 23.00K | ▲ 38.00K | ▼ -3.00K |
Net Income | -6.48M | ▼ -14.90M | ▼ -21.50M | ▼ -22.71M | ▲ -20.45M | ▲ -18.82M | ▼ -40.11M |
Net Income Ratio | -4.37 | ▲ 0.00 | 0.00 | 0.00 | ▼ -5.61 | ▼ -100.00 | ▲ 0.00 |
Eps | -0.39 | ▼ -0.62 | ▼ -0.65 | ▲ -0.35 | ▲ -0.31 | ▲ -0.20 | ▼ -9.34 |
Eps Diluted | -0.39 | ▼ -0.62 | ▼ -0.65 | ▲ -0.35 | ▲ -0.31 | ▲ -0.20 | ▼ -9.34 |
Weighted Average Shs Out | 16.59M | ▲ 23.97M | ▲ 33.01M | ▲ 65.07M | ▲ 65.95M | ▲ 95.40M | ▼ 4.29M |
Weighted Average Shs Out Dil | 16.59M | ▲ 23.97M | ▲ 33.01M | ▲ 65.07M | ▲ 65.95M | ▲ 95.40M | ▼ 4.29M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 12.82M | ▲ 22.46M | ▼ 19.25M | ▲ 90.10M | ▼ 15.14M | ▲ 34.86M | ▲ 90.59M |
Short Term Investments | 37.48M | ▲ 52.05M | ▲ 52.70M | ▲ 56.18M | ▲ 77.99M | ▼ 20.85M | ▲ 113.01M |
Cash And Short Term Investments | 50.30M | ▲ 74.51M | ▼ 71.95M | ▲ 146.27M | ▼ 93.13M | ▼ 55.71M | ▲ 203.60M |
Net Receivables | 3.08M | ▼ 0.00 | 0.00 | 0.00 | ▲ 815.00K | ▼ 375.00K | ▼ 163.00K |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 6.17M | ▼ 2.19M |
Total Current Assets | 54.99M | ▲ 76.67M | ▼ 74.51M | ▲ 149.79M | ▼ 98.89M | ▼ 62.26M | ▲ 205.95M |
Property Plant Equipment Net | 854.00K | ▲ 1.02M | ▲ 7.11M | ▲ 9.87M | ▼ 8.36M | ▼ 6.65M | ▼ 0.00 |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 232.00K | ▼ 50.00K | ▲ 1.57M | ▲ 1.96M | ▲ 2.68M | ▼ 2.24M | ▼ 1.32M |
Total Non Current Assets | 1.09M | ▼ 1.07M | ▲ 8.68M | ▲ 11.83M | ▼ 11.04M | ▼ 8.89M | ▼ 1.32M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 56.08M | ▲ 77.74M | ▲ 83.18M | ▲ 161.62M | ▼ 109.93M | ▼ 71.14M | ▲ 207.27M |
Account Payables | 389.00K | ▲ 663.00K | ▲ 3.15M | ▼ 2.25M | ▲ 3.32M | ▼ 677.00K | ▲ 1.68M |
Short Term Debt | 5.06M | ▼ 0.00 | ▲ 351.00K | ▼ 319.00K | ▲ 436.00K | ▲ 625.00K | ▼ 0.00 |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 20.00K | ▼ 0.00 | ▲ 14.39M | ▼ 13.41M | ▼ 2.36M | ▼ 517.00K | ▼ 0.00 |
Other Current Liabilities | 5.22M | ▲ 9.58M | ▲ 14.85M | ▼ 13.87M | ▲ 14.03M | ▼ 12.84M | ▲ 43.19M |
Total Current Liabilities | 5.63M | ▲ 10.24M | ▲ 18.36M | ▼ 16.44M | ▲ 20.14M | ▼ 14.66M | ▲ 44.87M |
Long Term Debt | 0.00 | 0.00 | ▲ 4.71M | ▲ 5.13M | ▼ 4.62M | ▼ 4.00M | ▼ 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.22M | ▲ 2.18M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 111.00K | ▼ 72.00K | ▼ 31.00K | ▲ 214.00K | ▼ 0.00 | 0.00 | ▲ 407.80M |
Total Non Current Liabilities | 111.00K | ▼ 72.00K | ▲ 4.74M | ▲ 5.34M | ▲ 5.84M | ▲ 6.18M | ▲ 407.80M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | ▲ 5.06M | ▲ 5.45M | ▼ 5.06M | ▼ 4.63M | ▼ 0.00 |
Total Liabilities | 5.74M | ▲ 10.31M | ▲ 23.10M | ▼ 21.79M | ▲ 25.99M | ▼ 20.84M | ▲ 452.67M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 387.11M |
Common Stock | 2.00K | 2.00K | ▲ 3.00K | ▲ 5.00K | 5.00K | ▲ 6.00K | ▲ 7.00K |
Retained Earnings | -72.51M | ▼ -116.86M | ▼ -195.12M | ▼ -276.01M | ▼ -341.81M | ▼ -425.62M | ▼ -701.23M |
Accumulated Other Comprehensive Income Loss | -102.00K | ▲ -27.00K | ▲ 51.00K | ▼ 11.00K | ▼ -20.00K | ▼ -48.00K | ▼ -132.00K |
Other Total Stockholders Equity | 122.95M | ▲ 184.31M | ▲ 255.14M | ▲ 415.82M | ▲ 425.77M | ▲ 475.97M | ▼ 68.85M |
Total Stockholders Equity | 50.34M | ▲ 67.43M | ▼ 60.08M | ▲ 139.83M | ▼ 83.94M | ▼ 50.31M | ▼ -245.40M |
Total Equity | 50.34M | ▲ 67.43M | ▼ 60.08M | ▲ 139.83M | ▼ 83.94M | ▼ 50.31M | ▼ -245.40M |
Total Liabilities And Stockholders Equity | 56.08M | ▲ 77.74M | ▲ 83.18M | ▲ 161.62M | ▼ 109.93M | ▼ 71.14M | ▲ 207.27M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 56.08M | ▲ 77.74M | ▲ 83.18M | ▲ 161.62M | ▼ 109.93M | ▼ 71.14M | ▲ 207.27M |
Total Investments | 37.48M | ▲ 52.05M | ▲ 52.70M | ▲ 56.18M | ▲ 77.99M | ▼ 20.85M | ▲ 113.01M |
Total Debt | 0.00 | 0.00 | ▲ 5.06M | ▲ 5.45M | ▼ 5.06M | ▼ 4.63M | ▼ 0.00 |
Net Debt | -12.82M | ▼ -22.46M | ▲ -14.19M | ▼ -84.65M | ▲ -10.08M | ▼ -30.23M | ▼ -90.59M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Net Income | -6.48M | ▼ -14.90M | ▼ -21.50M | ▼ -22.71M | ▲ -20.45M | ▲ -18.82M | ▼ -40.11M |
Depreciation And Amortization | 66.00K | ▲ 72.00K | ▲ 106.00K | ▲ 369.00K | ▲ 411.00K | ▼ 385.00K | ▼ 0.00 |
Deferred Income Tax | 0.00 | ▲ 86.00K | ▼ -63.00K | ▼ -64.00K | ▲ 88.00K | ▼ 0.00 | 0.00 |
Stock Based Compensation | 698.00K | ▲ 1.38M | ▼ 1.18M | ▲ 1.61M | ▲ 2.09M | ▼ 1.43M | ▲ 4.79M |
Change In Working Capital | -148.00K | ▲ 6.17M | ▼ 3.83M | ▼ 3.50M | ▼ -1.51M | ▲ -1.16M | ▼ -7.95M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -283.00K | ▼ -488.00K | ▲ 749.00K | ▼ -5.00K | ▲ 1.46M | ▼ -3.50M | ▲ -1.04M |
Other Working Capital | 135.00K | ▲ 6.66M | ▼ 3.08M | ▲ 3.50M | ▼ -2.97M | ▲ 2.34M | ▼ -6.91M |
Other Non Cash Items | -6.00K | ▲ 76.00K | ▲ 78.00K | ▲ 105.00K | ▲ 186.00K | ▼ 28.00K | ▲ 8.68M |
Net Cash Provided By Operating Activities | -5.87M | ▼ -7.20M | ▼ -16.29M | ▼ -17.13M | ▼ -19.27M | ▲ -18.14M | ▼ -34.60M |
Investments In Property Plant And Equipment | -191.00K | ▼ -203.00K | ▼ -1.17M | ▲ -1.00M | ▲ 0.00 | 0.00 | 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | -2.00M | ▼ -26.68M | ▲ -4.25M | ▼ -31.00M | ▲ -13.25M | ▲ -4.50M | ▼ -112.63M |
Sales Maturities Of Investments | 7.04M | ▲ 24.75M | ▼ 15.75M | ▲ 60.62M | ▼ 22.91M | ▼ 18.50M | ▼ 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 15.00M |
Net Cash Used For Investing Activities | 4.84M | ▼ -2.13M | ▲ 10.33M | ▲ 28.62M | ▼ 9.66M | ▲ 14.00M | ▼ -97.63M |
Debt Repayment | 0.00 | 0.00 | ▼ -7.00K | ▲ -6.00K | ▼ -169.00K | ▲ -8.00K | ▲ 0.00 |
Common Stock Issued | 0.00 | ▲ 16.39M | ▼ 59.00K | ▲ 24.61M | ▼ 0.00 | ▲ 42.98M | ▼ 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | ▲ 867.00K | ▼ 624.00K | ▼ 72.00K | ▲ 249.00K | ▼ -42.98M | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | 684.00K | ▲ 17.26M | ▼ 676.00K | ▲ 24.68M | ▼ 80.00K | ▼ -8.00K | ▼ -12.53M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | ▲ 47.00K | ▼ 3.00K | ▲ 46.00K | ▼ -17.00K |
Net Change In Cash | -345.00K | ▲ 7.93M | ▼ -5.29M | ▲ 36.21M | ▼ -9.52M | ▲ -4.10M | ▼ -144.78M |
Cash At End Of Period | 12.82M | ▲ 22.46M | ▼ 20.75M | ▲ 91.94M | ▼ 16.98M | ▲ 36.42M | ▲ 91.90M |
Cash At Beginning Of Period | 13.16M | ▲ 14.53M | ▲ 26.05M | ▲ 55.72M | ▼ 26.50M | ▲ 40.52M | ▲ 236.68M |
Operating Cash Flow | -5.87M | ▼ -7.20M | ▼ -16.29M | ▼ -17.13M | ▼ -19.27M | ▲ -18.14M | ▼ -34.60M |
Capital Expenditure | -191.00K | ▼ -203.00K | ▼ -1.17M | ▲ -1.00M | ▲ 0.00 | 0.00 | 0.00 |
Free Cash Flow | -6.06M | ▼ -7.40M | ▼ -17.47M | ▼ -18.13M | ▼ -19.27M | ▲ -18.14M | ▼ -34.60M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)